top of page
Companies in the News
Indigo Named #18 On 2018 CNBC Disruptor 50 List, Which Spotlights Companies That Are Changing Their
Indigo is recognized alongside most ambitious and innovative companies representing breakthrough ideas from all over the world Boston,...
May 23, 2018
Escient Pharmaceuticals Launches with $40 Million Series A Financing to Advance First-in-Class G Pro
-- Strategic focus on unleashing therapeutic potential of specific orphan GPCRs, including novel family of Mas-Related G-Protein...
May 9, 2018
Unity Biotech IPO Raises $85M to Test Drugs for Diseases of Aging
Xconomy San Francisco — Unity Biotechnology has yet to show that its drugs can treat diseases of aging in humans, but it now has $85...
May 3, 2018
UNITY Biotechnology, Inc. Completes $55 Million Series C Financing
SAN FRANCISCO, March 19, 2018 /PRNewswire/ -- UNITY Biotechnology, Inc. ("UNITY"), a privately held biotechnology company developing...
Mar 20, 2018
Indigo Cotton™ Demonstrates Continuous Improvement with Significant Yield Gains in Second Commercial
Indigo Cotton demonstrates a 14% average yield increase on commercial fields in water-stressed Texas Yield gains reflect year-over-year...
Mar 14, 2018
EBR Systems, Inc. Initiates Global Trial of World’s Only Wireless CRT Pacing Technology
Tiny Wireless Electrode Potentially Expands Heart Failure Therapy SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the...
Mar 7, 2018
Indigo Launches On-Farm Storage to Facilitate a Direct Farmer-to-Buyer Grain Marketplace
On-farm storage program enables identity preservation of grain and improves farm margins This U.S. program is a key step in building a...
Mar 2, 2018
Former Receptos Executives Launch Gossamer Bio, Inc., a New Biopharma Company Focused on Discovering
Co-founded by Faheem Hasnain and Sheila Gujrathi, M.D., former executive leadership of Receptos, Inc. Omega Funds founding seed investor...
Jan 4, 2018
Millendo Therapeutics acquires French biopharmaceutical company
Millendo Therapeutics acquires Alize Pharma in stock-based transaction Merger beefs up Millendo's congenital adrenal hyperplasia program...
Dec 21, 2017
bottom of page